{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "25aef87c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "================================\u001b[1m Human Message \u001b[0m=================================\n",
      "\n",
      "I have this patient in MTB :  \"Mrs. Brown, identified in our system as X11-01A, is a 49-year-old female patient who has been navigating her journey with metastatic colorectal cancer since 2019. \n",
      "            Her treatment history includes chemotherapy followed by surgical interventions, specifically a total mesorectal excision and a right-sided hemi-hepatectomy. In the previous year, a follow-up \n",
      "            CT scan revealed the presence of a single metastasis in the liver, prompting the initiation of a chemotherapy regimen that combined FOLFOX with Panitumumab. Currently, Mrs.\n",
      "            Brown returns with a new CT scan dated February 10, 2024, ordered by her oncologist.\"\n",
      "            I am asking you what is the best targeted therapeutical recommandation for this patient ? \n",
      "==================================\u001b[1m Ai Message \u001b[0m==================================\n",
      "Name: supervisor\n",
      "\n",
      "Given the information provided about Mrs. Brown's case, it seems she has been undergoing treatment for metastatic colorectal cancer with a history of chemotherapy and surgical interventions. The current recommendation from her oncologist involves a follow-up CT scan to monitor the condition.\n",
      "\n",
      "Based on the previous treatment regimen (FOLFOX combined with Panitumumab), which is a common first-line therapy for metastatic colorectal cancer, we need to consider potential next steps or targeted therapies that could be beneficial. Here are some considerations:\n",
      "\n",
      "1. **Rechallenge with FOLFOX and Panitumumab**: Since the initial regimen was effective, rechallenging her with the same combination might be a reasonable option if there is no evidence of resistance.\n",
      "\n",
      "2. **Alternative Chemotherapy Regimens**: If there's a need to switch due to toxicity or lack of response, other chemotherapy options such as FOLFIRI (Fluorouracil, Leucovorin, Irinotecan) combined with Cetuximab could be considered.\n",
      "\n",
      "3. **Targeted Therapies and Biologics**: Given the presence of liver metastases, targeted therapies like Bevacizumab (anti-VEGF), Regorafenib, or TAS-102 might be beneficial depending on the molecular profile of her tumor.\n",
      "\n",
      "4. **Immunotherapy**: If the patient has specific biomarkers that indicate a potential response to immunotherapy, such as high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR), then drugs like Pembrolizumab could be considered.\n",
      "\n",
      "5. **Clinical Trials**: Participation in clinical trials might offer access to novel treatments not yet widely available.\n",
      "\n",
      "To provide the most accurate and personalized recommendation, it would be beneficial to review her tumor's molecular profile, including biomarkers such as KRAS, NRAS, BRAF, MSI status, and others that could guide targeted therapy decisions. Additionally, discussing with an oncologist who specializes in colorectal cancer might help tailor a more specific treatment plan.\n",
      "\n",
      "Would you like me to look up the latest clinical guidelines or studies related to metastatic colorectal cancer for further insights?\n"
     ]
    }
   ],
   "source": [
    "from langchain_ollama import ChatOllama\n",
    "from langchain.agents import create_agent\n",
    "from langgraph_supervisor import create_supervisor\n",
    "import langchain\n",
    "from tools.pubmed_search import pubmed\n",
    "\n",
    "\n",
    "model = ChatOllama(\n",
    "    model=\"qwen2.5:7b\",           \n",
    "    temperature=0,            \n",
    ")\n",
    "\n",
    "# Create specialized agents\n",
    "\n",
    "\n",
    "pubmed_agent = create_agent(\n",
    "    model=model,\n",
    "    tools=[pubmed],\n",
    "    name=\"pubmed_expert\",\n",
    "    system_prompt=\"You are a world class researcher with access to pubmed search. Find usefull sources for the patient case\"\n",
    ")\n",
    "\n",
    "# screenfail_agent = create_agent(\n",
    "#     model=model,\n",
    "#     tools=[screenfail],\n",
    "#     name=\"screenfail_expert\",\n",
    "#     system_prompt=\"You are a screenfail expert. Do not do any cgi clinics.\"\n",
    "# )\n",
    "\n",
    "# biomolecular_agent = create_agent(\n",
    "#     model=model,\n",
    "#     tools=[cgi_clinics, pubmed],\n",
    "#     name=\"biomolecular_expert\",\n",
    "#     system_prompt=\"You are a world class biomolecular expert with access to CGI-Clinics. Always use one tool at a time. Find some clinical trials targeted the oncogenic mutation you find for the patient case\"\n",
    "# )\n",
    "\n",
    "# Create supervisor workflow\n",
    "workflow = create_supervisor(\n",
    "    [pubmed_agent],\n",
    "    model=model,\n",
    "    system_prompt=(\n",
    "        \"You are a supervisor doctor managing a pubmed researcher in a moleculare tumor board in oncology.\"\n",
    "        \"For every question of the user, use pubmed_agent.\"\n",
    "    )\n",
    ")\n",
    "\n",
    "# Compile and run\n",
    "app = workflow.compile()\n",
    "result = app.invoke({\n",
    "    \"messages\": [\n",
    "        {\n",
    "            \"role\": \"user\",\n",
    "            \"content\": \"\"\"I have this patient in MTB :  \"Mrs. Brown, identified in our system as X11-01A, is a 49-year-old female patient who has been navigating her journey with metastatic colorectal cancer since 2019. \n",
    "            Her treatment history includes chemotherapy followed by surgical interventions, specifically a total mesorectal excision and a right-sided hemi-hepatectomy. In the previous year, a follow-up \n",
    "            CT scan revealed the presence of a single metastasis in the liver, prompting the initiation of a chemotherapy regimen that combined FOLFOX with Panitumumab. Currently, Mrs.\n",
    "            Brown returns with a new CT scan dated February 10, 2024, ordered by her oncologist.\"\n",
    "            I am asking you what is the best targeted therapeutical recommandation for this patient ? \"\"\"\n",
    "        }\n",
    "    ]\n",
    "})\n",
    "\n",
    "for m in result[\"messages\"]:\n",
    "    m.pretty_print()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
